Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1.15B
-
Number of holders
-
787
-
Total 13F shares, excl. options
-
568M
-
Shares change
-
-25.8M
-
Total reported value, excl. options
-
$26.1B
-
Value change
-
-$1.25B
-
Put/Call ratio
-
0.99
-
Number of buys
-
328
-
Number of sells
-
-391
-
Price
-
$46.01
Significant Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2016
927 filings reported holding TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share as of Q3 2016.
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) has 787 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 568M shares
of 1.15B outstanding shares and own 49.5% of the company stock.
Largest 10 shareholders include FMR LLC (67.6M shares), FRANKLIN RESOURCES INC (46.9M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (26.6M shares), Capital Research Global Investors (20.9M shares), Viking Global Investors LP (19.7M shares), LAZARD ASSET MANAGEMENT LLC (17.4M shares), WADDELL & REED FINANCIAL INC (17.3M shares), Bank of New York Mellon Corp (16.1M shares), PAULSON & CO. INC. (16.1M shares), and Invesco Ltd. (14.3M shares).
This table shows the top 787 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.